Report Detail
Global Antiprotozoal Drugs Market Size, Status and Forecast 2020-2026
- RnM4208741 |
- 16 September, 2020 |
- Global |
- 152 Pages |
- QYResearch |
- Pharma & Healthcare
Antiprotozoal Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiprotozoal Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
by Diseases
Amoebic Dysentery
Antimalarial Drug
Leishmaniasis & Chagas Disease
by Drugs
Metronidazole
Atovaquone
Benznidazole
Dehydroemetine
Eflornithine
Emetine
Fenbendazole
Iodoquinol
Melarsoprol
Others (like Meglumine antimonite, Nifurtimox, Pentamidine, etc.)
Market segment by Application, split into
Hospital
Clinic
Based on regional and country-level analysis, the Antiprotozoal Drugs market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Antiprotozoal Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Sanofi
Akthelia Pharmaceuticals Ltd
GlaxoSmithKline Plc
Immuron Ltd
Microbiotix Inc
Protein Potential LLC
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corp.
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals
Gilead Sciences
Johnson & Johnson
Bristol-Myers Squibb
Profounda
Knight Therapeutics
Albert David
Wanlong
Fangsheng
KPC Pharmaceuticals
Guilin Pharmaceuticals
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Antiprotozoal Drugs Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Amoebic Dysentery
- 1.2.3 Antimalarial Drug
- 1.2.4 Leishmaniasis & Chagas Disease
- 1.3 Market by Application
- 1.3.1 Global Antiprotozoal Drugs Market Share by Application: 2020 VS 2026
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Antiprotozoal Drugs Market Perspective (2015-2026)
- 2.2 Global Antiprotozoal Drugs Growth Trends by Regions
- 2.2.1 Antiprotozoal Drugs Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Antiprotozoal Drugs Historic Market Share by Regions (2015-2020)
- 2.2.3 Antiprotozoal Drugs Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Antiprotozoal Drugs Players by Market Size
- 3.1.1 Global Top Antiprotozoal Drugs Players by Revenue (2015-2020)
- 3.1.2 Global Antiprotozoal Drugs Revenue Market Share by Players (2015-2020)
- 3.2 Global Antiprotozoal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Antiprotozoal Drugs Revenue
- 3.4 Global Antiprotozoal Drugs Market Concentration Ratio
- 3.4.1 Global Antiprotozoal Drugs Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Antiprotozoal Drugs Revenue in 2019
- 3.5 Key Players Antiprotozoal Drugs Area Served
- 3.6 Key Players Antiprotozoal Drugs Product Solution and Service
- 3.7 Date of Enter into Antiprotozoal Drugs Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Antiprotozoal Drugs Breakdown Data by Type (2015-2026)
- 4.1 Global Antiprotozoal Drugs Historic Market Size by Type (2015-2020)
- 4.2 Global Antiprotozoal Drugs Forecasted Market Size by Type (2021-2026)
5 Antiprotozoal Drugs Breakdown Data by Application (2015-2026)
- 5.1 Global Antiprotozoal Drugs Historic Market Size by Application (2015-2020)
- 5.2 Global Antiprotozoal Drugs Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Antiprotozoal Drugs Market Size (2015-2026)
- 6.2 North America Antiprotozoal Drugs Market Size by Type (2015-2020)
- 6.3 North America Antiprotozoal Drugs Market Size by Application (2015-2020)
- 6.4 North America Antiprotozoal Drugs Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Antiprotozoal Drugs Market Size (2015-2026)
- 7.2 Europe Antiprotozoal Drugs Market Size by Type (2015-2020)
- 7.3 Europe Antiprotozoal Drugs Market Size by Application (2015-2020)
- 7.4 Europe Antiprotozoal Drugs Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Antiprotozoal Drugs Market Size (2015-2026)
- 8.2 China Antiprotozoal Drugs Market Size by Type (2015-2020)
- 8.3 China Antiprotozoal Drugs Market Size by Application (2015-2020)
- 8.4 China Antiprotozoal Drugs Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Antiprotozoal Drugs Market Size (2015-2026)
- 9.2 Japan Antiprotozoal Drugs Market Size by Type (2015-2020)
- 9.3 Japan Antiprotozoal Drugs Market Size by Application (2015-2020)
- 9.4 Japan Antiprotozoal Drugs Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 India
- 10.1 India Antiprotozoal Drugs Market Size (2015-2026)
- 10.2 India Antiprotozoal Drugs Market Size by Type (2015-2020)
- 10.3 India Antiprotozoal Drugs Market Size by Application (2015-2020)
- 10.4 India Antiprotozoal Drugs Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Company Details
- 11.1.2 Sanofi Business Overview
- 11.1.3 Sanofi Antiprotozoal Drugs Introduction
- 11.1.4 Sanofi Revenue in Antiprotozoal Drugs Business (2015-2020))
- 11.1.5 Sanofi Recent Development
- 11.2 Akthelia Pharmaceuticals Ltd
- 11.2.1 Akthelia Pharmaceuticals Ltd Company Details
- 11.2.2 Akthelia Pharmaceuticals Ltd Business Overview
- 11.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Introduction
- 11.2.4 Akthelia Pharmaceuticals Ltd Revenue in Antiprotozoal Drugs Business (2015-2020)
- 11.2.5 Akthelia Pharmaceuticals Ltd Recent Development
- 11.3 GlaxoSmithKline Plc
- 11.3.1 GlaxoSmithKline Plc Company Details
- 11.3.2 GlaxoSmithKline Plc Business Overview
- 11.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Introduction
- 11.3.4 GlaxoSmithKline Plc Revenue in Antiprotozoal Drugs Business (2015-2020)
- 11.3.5 GlaxoSmithKline Plc Recent Development
- 11.4 Immuron Ltd
- 11.4.1 Immuron Ltd Company Details
- 11.4.2 Immuron Ltd Business Overview
- 11.4.3 Immuron Ltd Antiprotozoal Drugs Introduction
- 11.4.4 Immuron Ltd Revenue in Antiprotozoal Drugs Business (2015-2020)
- 11.4.5 Immuron Ltd Recent Development
- 11.5 Microbiotix Inc
- 11.5.1 Microbiotix Inc Company Details
- 11.5.2 Microbiotix Inc Business Overview
- 11.5.3 Microbiotix Inc Antiprotozoal Drugs Introduction
- 11.5.4 Microbiotix Inc Revenue in Antiprotozoal Drugs Business (2015-2020)
- 11.5.5 Microbiotix Inc Recent Development
- 11.6 Protein Potential LLC
- 11.6.1 Protein Potential LLC Company Details
- 11.6.2 Protein Potential LLC Business Overview
- 11.6.3 Protein Potential LLC Antiprotozoal Drugs Introduction
- 11.6.4 Protein Potential LLC Revenue in Antiprotozoal Drugs Business (2015-2020)
- 11.6.5 Protein Potential LLC Recent Development
- 11.7 Dr. Reddy’s Laboratories
- 11.7.1 Dr. Reddy’s Laboratories Company Details
- 11.7.2 Dr. Reddy’s Laboratories Business Overview
- 11.7.3 Dr. Reddy’s Laboratories Antiprotozoal Drugs Introduction
- 11.7.4 Dr. Reddy’s Laboratories Revenue in Antiprotozoal Drugs Business (2015-2020)
- 11.7.5 Dr. Reddy’s Laboratories Recent Development
- 11.8 Mission Pharmacal
- 11.8.1 Mission Pharmacal Company Details
- 11.8.2 Mission Pharmacal Business Overview
- 11.8.3 Mission Pharmacal Antiprotozoal Drugs Introduction
- 11.8.4 Mission Pharmacal Revenue in Antiprotozoal Drugs Business (2015-2020)
- 11.8.5 Mission Pharmacal Recent Development
- 11.9 Aceto Corp.
- 11.9.1 Aceto Corp. Company Details
- 11.9.2 Aceto Corp. Business Overview
- 11.9.3 Aceto Corp. Antiprotozoal Drugs Introduction
- 11.9.4 Aceto Corp. Revenue in Antiprotozoal Drugs Business (2015-2020)
- 11.9.5 Aceto Corp. Recent Development
- 11.10 Mylan Pharmaceuticals
- 11.10.1 Mylan Pharmaceuticals Company Details
- 11.10.2 Mylan Pharmaceuticals Business Overview
- 11.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Introduction
- 11.10.4 Mylan Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2015-2020)
- 11.10.5 Mylan Pharmaceuticals Recent Development
- 11.11 Impax Laboratories
- 10.11.1 Impax Laboratories Company Details
- 10.11.2 Impax Laboratories Business Overview
- 10.11.3 Impax Laboratories Antiprotozoal Drugs Introduction
- 10.11.4 Impax Laboratories Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.11.5 Impax Laboratories Recent Development
- 11.12 Pfizer
- 10.12.1 Pfizer Company Details
- 10.12.2 Pfizer Business Overview
- 10.12.3 Pfizer Antiprotozoal Drugs Introduction
- 10.12.4 Pfizer Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.12.5 Pfizer Recent Development
- 11.13 Lupin Pharmaceuticals
- 10.13.1 Lupin Pharmaceuticals Company Details
- 10.13.2 Lupin Pharmaceuticals Business Overview
- 10.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Introduction
- 10.13.4 Lupin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.13.5 Lupin Pharmaceuticals Recent Development
- 11.14 Glenmark Pharmaceuticals
- 10.14.1 Glenmark Pharmaceuticals Company Details
- 10.14.2 Glenmark Pharmaceuticals Business Overview
- 10.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Introduction
- 10.14.4 Glenmark Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.14.5 Glenmark Pharmaceuticals Recent Development
- 11.15 Sun Pharmaceutical
- 10.15.1 Sun Pharmaceutical Company Details
- 10.15.2 Sun Pharmaceutical Business Overview
- 10.15.3 Sun Pharmaceutical Antiprotozoal Drugs Introduction
- 10.15.4 Sun Pharmaceutical Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.15.5 Sun Pharmaceutical Recent Development
- 11.16 Heritage Pharmaceuticals
- 10.16.1 Heritage Pharmaceuticals Company Details
- 10.16.2 Heritage Pharmaceuticals Business Overview
- 10.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Introduction
- 10.16.4 Heritage Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.16.5 Heritage Pharmaceuticals Recent Development
- 11.17 Gilead Sciences
- 10.17.1 Gilead Sciences Company Details
- 10.17.2 Gilead Sciences Business Overview
- 10.17.3 Gilead Sciences Antiprotozoal Drugs Introduction
- 10.17.4 Gilead Sciences Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.17.5 Gilead Sciences Recent Development
- 11.18 Johnson & Johnson
- 10.18.1 Johnson & Johnson Company Details
- 10.18.2 Johnson & Johnson Business Overview
- 10.18.3 Johnson & Johnson Antiprotozoal Drugs Introduction
- 10.18.4 Johnson & Johnson Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.18.5 Johnson & Johnson Recent Development
- 11.19 Bristol-Myers Squibb
- 10.19.1 Bristol-Myers Squibb Company Details
- 10.19.2 Bristol-Myers Squibb Business Overview
- 10.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Introduction
- 10.19.4 Bristol-Myers Squibb Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.19.5 Bristol-Myers Squibb Recent Development
- 11.20 Profounda
- 10.20.1 Profounda Company Details
- 10.20.2 Profounda Business Overview
- 10.20.3 Profounda Antiprotozoal Drugs Introduction
- 10.20.4 Profounda Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.20.5 Profounda Recent Development
- 11.21 Knight Therapeutics
- 10.21.1 Knight Therapeutics Company Details
- 10.21.2 Knight Therapeutics Business Overview
- 10.21.3 Knight Therapeutics Antiprotozoal Drugs Introduction
- 10.21.4 Knight Therapeutics Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.21.5 Knight Therapeutics Recent Development
- 11.22 Albert David
- 10.22.1 Albert David Company Details
- 10.22.2 Albert David Business Overview
- 10.22.3 Albert David Antiprotozoal Drugs Introduction
- 10.22.4 Albert David Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.22.5 Albert David Recent Development
- 11.23 Wanlong
- 10.23.1 Wanlong Company Details
- 10.23.2 Wanlong Business Overview
- 10.23.3 Wanlong Antiprotozoal Drugs Introduction
- 10.23.4 Wanlong Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.23.5 Wanlong Recent Development
- 11.24 Fangsheng
- 10.24.1 Fangsheng Company Details
- 10.24.2 Fangsheng Business Overview
- 10.24.3 Fangsheng Antiprotozoal Drugs Introduction
- 10.24.4 Fangsheng Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.24.5 Fangsheng Recent Development
- 11.25 KPC Pharmaceuticals
- 10.25.1 KPC Pharmaceuticals Company Details
- 10.25.2 KPC Pharmaceuticals Business Overview
- 10.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Introduction
- 10.25.4 KPC Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.25.5 KPC Pharmaceuticals Recent Development
- 11.26 Guilin Pharmaceuticals
- 10.26.1 Guilin Pharmaceuticals Company Details
- 10.26.2 Guilin Pharmaceuticals Business Overview
- 10.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Introduction
- 10.26.4 Guilin Pharmaceuticals Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.26.5 Guilin Pharmaceuticals Recent Development
- 11.27 Pude Pharmaceutica
- 10.27.1 Pude Pharmaceutica Company Details
- 10.27.2 Pude Pharmaceutica Business Overview
- 10.27.3 Pude Pharmaceutica Antiprotozoal Drugs Introduction
- 10.27.4 Pude Pharmaceutica Revenue in Antiprotozoal Drugs Business (2015-2020)
- 10.27.5 Pude Pharmaceutica Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Antiprotozoal Drugs. Industry analysis & Market Report on Antiprotozoal Drugs is a syndicated market report, published as Global Antiprotozoal Drugs Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Antiprotozoal Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
